What causes secondary polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Secondary Polycythemia Causes

Secondary polycythemia is caused by either hypoxia-driven or hypoxia-independent processes that lead to a true increase in red blood cell mass, distinct from relative polycythemia which results from plasma volume depletion. 1

Hypoxia-Driven Causes

  • Chronic lung disease - conditions that impair oxygen exchange in the lungs lead to compensatory erythropoiesis 1
  • Right-to-left cardiopulmonary shunts - allowing deoxygenated blood to bypass the lungs 1
  • High-altitude habitation - lower atmospheric oxygen pressure triggers increased red cell production 1
  • Hypoventilation syndromes including sleep apnea - intermittent hypoxia during sleep stimulates erythropoietin production 1
  • Smoking - carbon monoxide from cigarette smoke binds to hemoglobin with 200-250 times greater affinity than oxygen, creating functional hypoxia and triggering compensatory erythropoiesis 1, 2

Hypoxia-Independent Causes

  • Malignant tumors - particularly renal cell carcinoma and hepatocellular carcinoma that secrete erythropoietin 1, 3
  • Benign tumors - including uterine leiomyomas, pheochromocytoma, and meningioma can produce erythropoietin 1
  • Congenital causes:
    • Abnormally elevated set point for EPO production 1
    • Abnormal oxygen homeostasis (Chuvash polycythemia) 1
    • EPOR-mediated causes (some cases of autosomal-dominant congenital polycythemia) 1
    • High oxygen-affinity hemoglobinopathy (congenital, autosomal-dominant) 1, 4
    • Mutations of the Erythropoietin-receptor gene 4
    • 2,3-bisphosphoglycerate mutase deficiency 4
  • Exogenous administration of erythropoietic drugs (EPO, androgen preparations) 1
  • Post-renal transplant erythrocytosis (PRTE) 1

Distinguishing Secondary Polycythemia from Other Types

  • Secondary polycythemia must be differentiated from:
    • Relative polycythemia - normal red cell mass with decreased plasma volume due to dehydration, diarrhea, vomiting, diuretic use, or burns 5, 1
    • Polycythemia vera - a myeloproliferative neoplasm characterized by JAK2 gene variant (present in >95% of cases) 6

Diagnostic Approach

  • Determine if polycythemia is true (increased red cell mass) or apparent (normal red cell mass with decreased plasma volume) 1
  • Assess for clinical signs of plasma volume depletion 1
  • Evaluate for hypoxemia through arterial blood gas analysis or pulse oximetry 1
  • Check serum EPO levels - typically elevated in secondary polycythemia but may normalize once hemoglobin stabilizes at a higher level 1, 7
  • Consider JAK2 mutation analysis to rule out polycythemia vera 4, 6, 8
  • Perform hemoglobin electrophoresis if high oxygen-affinity hemoglobinopathy is suspected 4
  • Consider sleep study for suspected sleep apnea 1
  • Imaging studies may be needed to identify potential tumors causing erythropoietin production 3, 7

Clinical Pearls and Pitfalls

  • Smoker's polycythemia is a real condition that resolves with smoking cessation, with risk reduction beginning within 1 year 1, 2
  • Serum EPO levels may be normal in chronic hypoxic states after hemoglobin stabilizes at a higher level 1
  • Unnecessary red cell mass measurements can be avoided when the cause of polycythemia is clinically obvious 5, 1
  • Secondary polycythemia due to erythropoietin-secreting tumors (like renal cell carcinoma) may resolve after tumor removal 3
  • Secondary polycythemia increases blood viscosity, which can lead to thrombotic events such as ischemic stroke 2, 3

References

Guideline

Secondary Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Smoking-Induced Polycythemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Congenital and acquired polycythemias.

Deutsches Arzteblatt international, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Secondary polycythemias: the role of erythropoietin].

Revue medicale de la Suisse romande, 1993

Research

[How I manage polycythemia].

Revue medicale de Liege, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.